Synthesis and antitumor activity of some novel thiophene, pyrimidine, coumarin, pyrazole and pyridine derivatives

dc.AffiliationOctober University for modern sciences and Arts (MSA)
dc.contributor.authorAlbratty M.
dc.contributor.authorEl-Sharkawy K.A.
dc.contributor.authorAlam S.
dc.contributor.otherDepartment of Pharmaceutical Chemistry
dc.contributor.otherCollege of Pharmacy Jazan University
dc.contributor.otherP.O. Box 114
dc.contributor.otherJazan
dc.contributor.other45142
dc.contributor.otherSaudi Arabia; Department of Organic Chemistry
dc.contributor.otherFaculty of Biotechnology
dc.contributor.otherOctober University for Modern Sciences and Arts (MSA)
dc.contributor.otherEl-Wahat Road 6
dc.contributor.otherOctober City
dc.contributor.otherEgypt
dc.date.accessioned2020-01-09T20:41:22Z
dc.date.available2020-01-09T20:41:22Z
dc.date.issued2017
dc.descriptionScopus
dc.description.abstract2-Cyano-N-(thiazol-2-yl) acetamide (2a) and 2-cyano-N-(oxazol- 2-yl) acetamide (2b) were obtained via the reaction of ethyl cyanoacetate with either 2-aminothiazole (1a) or 2-aminooxazole (1b). The formed products were directed toward the reaction with cyclopentanone and elemental sulfur in the presence of triethylamine to give cyclopenta[b]thiophene derivatives (3a,b). The latter products were reacted with either ethyl cyanoacetate or malononitrile to form compounds 4a,b and 5a,b, respectively. Compounds 4a,b were aimed at synthesizing some heterocyclic compounds; thus internal cyclization reactions were introduced to form compounds 6a,b. Also, compounds 4a,b reacted with salicylaldehyde, hydrazine derivatives and either urea or thiourea to produce coumarin derivatives (7a,b), pyrazole derivatives (8a-d) and pyrimidine derivatives (9a-d), respectively. Reaction of either benzaldehyde or benzene diazonium chloride (11) with compounds 4a,b afforded compounds 10a,b and 12a,b, respectively. On the other hand, compounds 5a,b underwent internal cyclization to form pyrimidine derivatives 13a,b. Also, when compounds 5a,b reacted with either ethyl cyanoacetate or malononitrile, they gave pyridine derivatives (15a-d) through the formation of intermediates (14a-d). Finally, formation of fused pyrimidine derivatives (17a,b) was achieved through the reaction of compounds 5a,b and salicylaldehyde applying two different pathways. The first pathway used a catalytic amount of piperidine to form compounds 16a,b; the latter products underwent cyclization to give compounds 17a,b. The second pathway, using a catalytic amount of sodium ethoxide solution directly in one step, afforded compounds 17a,b. Structures of the newly synthesized compounds were established using IR, 1H NMR, 13C NMR and mass spectrometry and their antitumor activity was investigated. Some of these compounds showed promising inhibitory effects on three different cell lines. However, fused pyrimidine acetonitrile derivatives 6a and 6b exerted the highest inhibitory effect, comparable to that of doxorubicin. � by Karam Ahmed El-Sharkawy 2017.en_US
dc.identifier.doihttps://doi.org/10.1515/acph-2017-0004
dc.identifier.doiPubMedID28231053
dc.identifier.issn13300075
dc.identifier.otherhttps://doi.org/10.1515/acph-2017-0004
dc.identifier.otherPubMedID28231053
dc.identifier.urihttps://t.ly/W5xwP
dc.language.isoEnglishen_US
dc.publisherCroatian Pharmaceutical Societyen_US
dc.relation.ispartofseriesActa Pharmaceutica
dc.relation.ispartofseries67
dc.subjectOctober University for Modern Sciences and Arts
dc.subjectUniversity for Modern Sciences and Arts
dc.subjectMSA University
dc.subjectجامعة أكتوبر للعلوم الحديثة والآداب
dc.subjectantitumor activityen_US
dc.subjectcoumarinen_US
dc.subjectpyrazoleen_US
dc.subjectpyridineen_US
dc.subjectpyrimidineen_US
dc.subjectthiopheneen_US
dc.subject2 (1 amino 2 cyanoethylideneamino) n (oxazol 2 yl) 5,6 dihydro 4h cyclopenta[b]thiophene 3 carboxamideen_US
dc.subject2 (1 amino 2 cyanoethylideneamino) n (thiazol 2 yl) 5,6 dihydro 4h cyclopenta[b]thiophene 3 carboxamideen_US
dc.subject2 (2 cyano 3 phenylacrylamido) n (oxazol 2 yl) 5,6 dihydro 4h cyclopenta[b]thiophene 3 carboxamideen_US
dc.subject2 (2 cyano 3 phenylacrylamido) n (thiazol 2 yl) 5,6 dihydro 4h cyclopenta[b]thiophene 3 carboxamideen_US
dc.subject2 (2 cyanoacetamido) n (oxazol 2 yl) 5,6 dihydro 4h cyclopenta[b]thiophene 3 carboxamideen_US
dc.subject2 (2 cyanoacetamido) n (thiazol 2 yl) 5,6 dihydro 4h cyclopenta[b]thiophene 3 carboxamideen_US
dc.subject2 (3 (oxazol 2 yl carbamoyl) 5,6 dihydro 4h cyclopenta[b]thiophen 2 ylamino) 2 oxo n phenylacetohydrazonoyl cyanideen_US
dc.subject2 (3 (thiazol 2 yl carbamoyl) 5,6 dihydro 4h cyclopenta[b]thiophen 2 ylamino) 2 oxo n phenylacetohydrazonoyl cyanideen_US
dc.subject2 (4 (amino oxazol 2 yl) 6,7 dihydro 5h cyclopenta[4,5]thieno[2,3 d]pyrimidin 2 yl) acetonitrileen_US
dc.subject2 (4 (aminothiazol 2 yl) 6,7 dihydro 5h cyclopenta[4,5]thieno[2,3 d]pyrimidin 2 yl) acetonitrileen_US
dc.subject2 (4 amino 5 cyano 6 hydroxylpyridin 2 ylamino) n (oxazol 2 yl) 5,6 dihydro 4h cyclopenta[b]thiophene 3 carboxamideen_US
dc.subject2 (4 oxo 3 (oxazol 2 yl) 3,4,6,7 tetrahydro 5h cyclopenta[4,5]thieno[2,3 d]pyrimidin 2 yl)acetonitrileen_US
dc.subject2 (4 oxo 3 (thiazol 2 yl) 3,4,6,7 tetrahydro 5h cyclopenta[4,5]thieno[2,3 d]pyrimidin 2 yl)acetonitrileen_US
dc.subject2 (4,6 diamino 5 cyanopyridin 2 ylamino) n (oxazol 2 yl) 5,6 dihydro 4h cyclopenta[b]thiophene 3 carboxamideen_US
dc.subject2 (4,6 diamino 5 cyanopyridin 2 ylamino) n (thiazol 2 yl) 5,6 dihydro 4h cyclopenta[b]thiophene 3 carboxamideen_US
dc.subject2 (5 amino 1h pyrazol 3 ylamino) n (oxazol 2 yl) 5,6 dihydro 4h cyclopenta[b]thiophene 3 carboxamideen_US
dc.subject2 (5 amino 1h pyrazol 3 ylamino) n (thiazol 2 yl) 5,6 dihydro 4h cyclopenta[b]thiophene 3 carboxamideen_US
dc.subject2 (6 amino 2 oxo 2,5 dihydropyrimidin 4 ylamino) n (oxazol 2 yl) 5,6 dihydro 4h cyclopenta[b]thiophene 3 carboxamideen_US
dc.subject2 (6 amino 2 oxo 2,5 dihydropyrimidin 4 ylamino) n (thiazol 2 yl) 5,6 dihydro 4h cyclopenta[b]thiophene 3 carboxamideen_US
dc.subject2 (6 amino 2 thioxo 2,5 dihydropyrimidin 4 ylamino) n (oxazol 2 yl) 5,6 dihydro 4h cyclopenta[b]thiophene 3 carboxamideen_US
dc.subject2 (6 amino 2 thioxo 2,5 dihydropyrimidin 4 ylamino) n (thiazol 2 yl) 5,6 dihydro 4h cyclopenta[b]thiophene 3 carboxamideen_US
dc.subject2 amino n (oxazol 2 yl) 5,6 dihydro 4h cyclopenta[b]thiophene 3 carboxamideen_US
dc.subject2 amino n (thiazol 2 yl) 5,6 dihydro 4h cyclopenta[b]thiophene 3 carboxamideen_US
dc.subject2 cyano n (oxazol 2 yl)acetamideen_US
dc.subject2 cyano n (thiazol 2 yl)acetamideen_US
dc.subjectantineoplastic agenten_US
dc.subjectdoxorubicinen_US
dc.subjectn (3 (oxazol 2 yl carbamoyl) 5,6 dihydro 4h cyclopenta[b]thiophen 2 yl 2 oxo 2h chromene 3 carboxamideen_US
dc.subjectn (3 (thiazol 2 yl carbamoyl) 5,6 dihydro 4h cyclopenta[b]thiophen 2 yl 2 oxo 2h chromene 3 carboxamideen_US
dc.subjectunclassified drugen_US
dc.subjectunindexed drugen_US
dc.subjectantineoplastic agenten_US
dc.subjectcoumarin derivativeen_US
dc.subjectpyrazole derivativeen_US
dc.subjectpyridine derivativeen_US
dc.subjectpyrimidine derivativeen_US
dc.subjectthiophene derivativeen_US
dc.subjectantineoplastic activityen_US
dc.subjectArticleen_US
dc.subjectcarbon nuclear magnetic resonanceen_US
dc.subjectcatalysisen_US
dc.subjectcell growthen_US
dc.subjectcell migrationen_US
dc.subjectcell proliferationen_US
dc.subjectcell viabilityen_US
dc.subjectcontrolled studyen_US
dc.subjectcyclizationen_US
dc.subjectdrug synthesisen_US
dc.subjecthumanen_US
dc.subjecthuman cellen_US
dc.subjectmass spectrometryen_US
dc.subjectproton nuclear magnetic resonanceen_US
dc.subjectstructure activity relationen_US
dc.subjectsynthesisen_US
dc.subjecttumor cell lineen_US
dc.subjectAntineoplastic Agentsen_US
dc.subjectCell Line, Tumoren_US
dc.subjectCoumarinsen_US
dc.subjectHumansen_US
dc.subjectPyrazolesen_US
dc.subjectPyridinesen_US
dc.subjectPyrimidinesen_US
dc.subjectStructure-Activity Relationshipen_US
dc.subjectThiophenesen_US
dc.titleSynthesis and antitumor activity of some novel thiophene, pyrimidine, coumarin, pyrazole and pyridine derivativesen_US
dc.typeArticleen_US
dcterms.isReferencedByRomagnoli, R., Baraldi, P.G., Lopez-Cara, C., Salvador, M.K., Preti, D., Tabrizi, M.A., Balzarini, J., Viola, G., Design synthesis, and biological evaluation of 3,5-disubstituted 2-aminothiophene derivatives as a novel class of antitumor agents (2014) Bioorg. Med. Chem, 22, pp. 5097-5109; Romagnoli, R., Baraldi, P.G., Carrion, M.D., Cara, C.L., Perti, D., Fruttarolo, F., Pavani, M.G., Hamel, E., Syn thesis, and biological evaluation of 2-and 3-aminobenzo[b]thiophene derivatives as antimitotic agents, and inhibitors of tubulin polymerization (2007) J. Med. Chem, 50, pp. 2273-2277; Stephens, C.E., Felder, T.M., Sowell, J.W., Andrei, G., Balzarini, J., Snoeck, R., De Clercq, E., Syn thesis and antiviral/antitumor evaluation of 2-amino-2-carboxamido-3-aryl-sulfonylthiophenes, and related compounds as a new class of diarylsulfones (2001) Bioorg. Med. Chem, 9, pp. 1123-1132; Sulzer-Mosse, S., Cederbaum, F., Lamberth, C., Berthon, G., Umarye, J., Grasso, V., Schlereth, A., Waldmeier, R., Syn thesis, and fungicidal activity of N-thiazol-4-yl-salicylamides, a new family of anti-oomycete compounds (2015) Bioorg. Med. Chem, 23, pp. 2129-2138; Padmavathi, V., Prema Kumari, C., Venkatesh, B.C., Padmaja, A., Syn thesis, and antimicrobial activity of amido linked pyrrolyl, and pyrazolyl-oxazoles thiazoles, and imidazoles (2011) Eur. J. Med. Chem, 46, pp. 5317-5326; Dewal, M.B., Wani, A.S., Vidaillac, C., Oupick�, D., Rybak, M.J., Firestine, S.M., Thieno[2,3-d] pyrimidinedione derivatives as antibacterial agents (2012) Eur. J. Med. Chem, 51, pp. 145-153; Mavrova, A.T., Wesselinova, D., Tsenov, J.A., Lubenov, L.A., Syn thesis and antiproliferative activity of some new thieno[2,3-d]pyrimidine-4-(3H)-ones containing 1,2,4-triazole, and 1 3,4-thiadiazole moiety (2014) Eur. J. Med. Chem, 86, pp. 676-683; Chimenti, F., Bizzarri, B., Bolasco, A., Secci, D., Chimenti, P., Carradori, S., Granese, A., Sisto, F., A novel class of selective anti-Helicobacter pylori agents 2-oxo-2H-chromene-3-carboxamide derivatives (2007) Bioorg. Med. Chem. Lett, 17, pp. 3065-3071; Bindi, S., Fancelli, D., Alli, C., Berta, D., Bertrand, J.A., Cameron, A.D., Cappella, P., Vianello, P., Thieno[3,2-c]pyrazoles: A novel class of Aurora inhibitors with favorable antitumor activity (2010) Bioorg. Med. Chem, 18, pp. 7113-7120; Ulloora, S., Shabaraya, R., Ranganathan, R., Adhikari, A.V., Synthesis anticonvulsant, and antiinflammatory studies of new 1,4-dihydropyridin-4-yl-phenoxyacetohydrazones (2013) Eur. J. Med. Chem, 70, pp. 341-349; Napoleon, A.A., Khan, F.R.N., Jeong, E.D., Chung, E.H., Potential antitubercular agents: Hexahydro-3-phenyl indazol-2-yl-(pyridine-4-yl) methanones from antitubercular drug isoniazid, and bis(substituted benzylidene) cycloalkanones (2015) Chin. Chem. Lett, 26, pp. 567-571; Malik, S., Ahuja, P., Sahu, K., Khan, S.A., Design, and synthesis of new 3-(benzo [d] isoxazol-3yl)-1-substituted pyrrolidine-2,5-dione derivatives as anti-convulsants (2014) Eur. J. Med. Chem, 84, pp. 42-50; Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J.T., Boyd, M.R., New colorimetric cytotoxicity assay for anticancer-drug screening (1990) J. Natl. Cancer Inst, 82, pp. 1107-1112; Monks, A., Scudiero, D., Skehan, P., Shoemaker, R., Paull, K., Vistica, D., Hose, C., Boyd, M.J., Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines (1991) J. Natl. Cancer Inst, 83, pp. 757-766
dcterms.sourceScopus

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
avatar_scholar_256.png
Size:
6.31 KB
Format:
Portable Network Graphics
Description:
Loading...
Thumbnail Image
Name:
[18469558 - Acta Pharmaceutica] Synthesis and antitumor activity of some novel thiophene, pyrimidine, coumarin, pyrazole and pyridine derivatives.pdf
Size:
374.61 KB
Format:
Adobe Portable Document Format
Description: